Literature DB >> 19870647

INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : I. EFFECT OF AGE ON THE INVASION OF THE BRAIN BY VIRUS INSTILLED IN THE NOSE.

A B Sabin1, P K Olitsky.   

Abstract

1. After intracerebral injection or nasal instillation of vesicular stomatitis virus in young or old mice, there was no evidence of a generalized, systemic or blood infection. 2. Within 1 hour after nasal instillation of as much as 100,000 M.C.L.D. in young or old mice, no virus (i.e., less than 60 to 70 M.C.L.D.) could be demonstrated in the nasal mucosa. 2 days later and thereafter virus was abundant in the nasal mucosa of young mice, while among old mice it remained undemonstrable in some and present in small amount in others. 3. Virus was not detected in the anterior rhinencephalon of young and old mice within a few minutes and 5 hours after nasal instillation, but was almost uniformly demonstrable in this region, although not in the rest of the brain, on the 2nd day. This indicated that the primary invasion of the brain occurred by the olfactory rather than the fifth nerve pathway. 4. The essential difference in the further pathogenesis of the disease between the young mice which succumb with encephalomyelitis (5th day) and the old mice which survive without showing clinical signs of brain involvement, is in the progression of the virus from the anterior rhinencephalon. In the young the rest of the brain is invaded, while in the old resistant mice it is not, the progression of virus being arrested somewhere in the anterior rhinencephalon. 5. Since minimal amounts of virus injected intracerebrally were shown to be disseminated quickly through the entire brain, killing old as well as young mice, it was clear that virus so inoculated must spread differently from that which reaches the brain by the olfactory pathway. 6. That the arrest of virus progression in the brains of certain old mice is the result of a preexisting, localized barrier, developed with age, and is not due to a rapidly acquired, specific, cerebral immunity was shown by the failure of old mice to resist an intracerebral injection of 1 to 10 M.C.L.D., 2, 3, 4, or 5 days after preliminary nasal instillation.

Entities:  

Year:  1937        PMID: 19870647      PMCID: PMC2133585          DOI: 10.1084/jem.66.1.15

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  AN ACQUIRED RESISTANCE OF GROWING ANIMALS TO CERTAIN NEUROTROPIC VIRUSES IN THE ABSENCE OF HUMORAL ANTIBODIES OR PREVIOUS EXPOSURE TO INFECTION.

Authors:  P K Olitsky; A B Sabin; H R Cox
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

  1 in total
  34 in total

1.  Anterograde or Retrograde Transsynaptic Circuit Tracing in Vertebrates with Vesicular Stomatitis Virus Vectors.

Authors:  Kevin T Beier; Nathan A Mundell; Y Albert Pan; Constance L Cepko
Journal:  Curr Protoc Neurosci       Date:  2016-01-04

2.  Uptake of exogenous proteins in mouse olfactory cells.

Authors:  K Kristensson; Y Olsson
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

3.  Sendai virus infection in the mouse brain: virus spread and long-term effects.

Authors:  K Kristensson; J Leestma; B Lundh; E Norrby
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

5.  [Mouse disease due to vesicular stomatitis virus. I. Spread of the virus dependent on the age of the mouse].

Authors:  D Falke; W P Rowe
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Long-distance interferon signaling within the brain blocks virus spread.

Authors:  Anthony N van den Pol; Siyuan Ding; Michael D Robek
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

7.  Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.

Authors:  David Cooper; Kevin J Wright; Priscilla C Calderon; Min Guo; Farooq Nasar; J Erik Johnson; John W Coleman; Margaret Lee; Cheryl Kotash; Irene Yurgelonis; Robert J Natuk; R Michael Hendry; Stephen A Udem; David K Clarke
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

8.  Lectin-binding pattern of neuroepithelial and respiratory epithelial cells in the mouse nasal cavity.

Authors:  B Lundh; U Brockstedt; K Kristensson
Journal:  Histochem J       Date:  1989-01

9.  Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.

Authors:  Jennifer L Konopka; Joseph M Thompson; Alan C Whitmore; Drue L Webb; Robert E Johnston
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

10.  Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.

Authors:  Jennifer A Schwartz; Linda Buonocore; Anjeanette Roberts; Amorsolo Suguitan; Darwyn Kobasa; Gary Kobinger; Heinz Feldmann; Kanta Subbarao; John K Rose
Journal:  Virology       Date:  2007-05-23       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.